HANSEN REE, Anne et al. Molecularly matched therapy in the context of sensitivity, resistance, and safety; patient outcomes in end-stage cancer – the MetAction study. Acta Oncologica, [S. l.], v. 59, n. 7, p. 733–740, 2020. DOI: 10.1080/0284186X.2020.1742377. Disponível em: https://medicaljournalssweden.se/actaoncologica/article/view/24238. Acesso em: 19 jul. 2026.